Squarepoint Ops LLC Exagen Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$13.9 - $22.0 $140,084 - $221,716	-10,078 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$11.19 - $16.05 $86,991 - $124,772	-7,774 Reduced 43.55%	10,078 $133,000
Q3 2020 Nov 16, 2020	BUY	$10.56 - $16.69 $42,208 - $66,709	3,997 Added 28.85%	17,852 $194,000
Q2 2020 Aug 14, 2020	SELL	$11.0 - $16.7 $25,498 - $38,710	-2,318 Reduced 14.33%	13,855 $172,000
Q1 2020 May 15, 2020	BUY	$12.7 - $25.95 $11,544 - $23,588	909 Added 5.96%	16,173 $258,000
Q4 2019 Feb 14, 2020	BUY	$12.61 - $28.48 $192,479 - $434,718	15,264 New	15,264 $388,000

6.41M

4.5K

400

Ticker XGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,260,400
Market Cap $89.8M
Description
Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States. It enables rheumatologists to care for patients through the diagnosis, prognosis, and monitoring of autoimmune and autoimmune-related diseases, including systemic lupus ery...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.